Company intelligence / Profile preview

CAIMED

Ownership: Private
Development stage: Other

Overview

CAIMED is an active healthcare research organization focused on generating knowledge, driving health innovation, and improving quality of life through clinical research. Recent projects include early detection studies for diabetes and publication of findings related to dengue virus circulation in Colombia.

Therapeutic areas: EndocrinologyInfectious Diseases
Modalities: Small moleculeBiologicCell therapyGene therapy
Industry: Academic Hospital/University/Research

Beyond the preview

Go deeper on CAIMED.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CAIMED.

Explore the full profile